The effects of 1-nitropyrene, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 7,12-dimethylbenz[a] anthracene on 8-hydroxy-2 '-deoxyguanosine levels in the rat mammary gland and modulation by dietary 1,4-phenylenebis(methylene)selenocyanate
K. El-bayoumy et al., The effects of 1-nitropyrene, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 7,12-dimethylbenz[a] anthracene on 8-hydroxy-2 '-deoxyguanosine levels in the rat mammary gland and modulation by dietary 1,4-phenylenebis(methylene)selenocyanate, CANCER LETT, 151(1), 2000, pp. 7-13
Humans are exposed to 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP
) and 1-nitropyrene (1-NP) via several environmental sources and both are k
nown mammary carcinogens in rodents, with the former being more potent (K.
El-Bayoumy, Y.-H. Chae, P. Upadhyaya, A. Rivenson, K. Kurtzke, B. Reddy, S.
S. Hecht, Comparative tumorigenicity of benzo[a]pyrene, 1-nitropyrene, and
2-amino-1-methyl-6-phenylimidazo [4,5-b]pyridine administered by gavage to
female CD rats, Carcinogenesis 16 (1995) 431-434). Following their metaboli
c activation, both carcinogens are known to bind covalently to DNA. However
, it remains to be determined whether these carcinogens can also induce DNA
-base oxidation. Our goal was to determine the effects of PhIP and 1-NP on
the levels of 8-hydroxy-2'-deoxyguanosine (8-OHdG; a marker of oxidative DN
A damage) in rat mammary glands and to evaluate the effect of the chemoprev
entive agent 1,4-phenylenebis(methylene)selenocyanate (p-XSC) as an inhibit
or of such damage. As an established potent mammary carcinogen, the synthet
ic 7,12-dimethylbenz[a]anthracene (DMBA) was included in this study. Female
CD rats were fed a high-far AIN-76A diet (23.5% corn oil) supplemented wit
h p-XSC (10 ppm as selenium) or unsupplemented control diet for 1 week. At
50 days of age, each rat (12 rats/group) was gavaged with either PhIP (22 m
g (100 mu mol) per rat) or 1-NP (20 mg (80 mu mol) per rat) in trioctanoin
(0.5 mi), DMBA (5 mg (20 mu mol) per rat) in olive oil (0.2 mi), or the cor
responding vehicle. Rats were sacrificed 6 and 24 h after carcinogen treatm
ent (six rats per time point). Mammary fat pads were excised and DNA was is
olated and enzymatically hydrolyzed. The hydrolysates were analyzed for 8-O
HdG using HPLC with EC detection. PhIP significantly increased the levels o
f 8-OHdG by 83% after 6 h (P < 0.05), but the increase (47%) at the 24 h po
int was not significant. p-XSC alone had no effect on the levels of 8-OHdG.
However, the elevation of 8-OHdG caused by PhIP at 6 h was significantly i
nhibited by p-XSC to levels similar to those measured in rats treated with
the vehicle only (P ( 0.05). p-XSC had no effect on PhIP-induced 8-OHdG at
24 h. 1-NP had no effect on the levels of 8-OHdG at either time point. Leve
ls of 8-OHdG were increased by 22% 6 h after DMBA administration and, signi
ficantly, rose to 84% at 24 h (P < 0.01); at either time point, this elevat
ion was not inhibited by p-XSC. Although the mechanisms remain to be determ
ined, to our knowledge, this is the first report demonstrating that PhIP an
d DMBA are capable of enhancing 8-OHdG levels in the rat mammary tissue in
vivo. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.